1. Biochemical control of the combination of cyclooxygenase‐2 inhibitor and 125I‐brachytherapy for prostate cancer: Post hoc analysis of an open‐label controlled randomized trial. (26th June 2020) Authors: Nakai, Yasushi; Tanaka, Nobumichi; Asakawa, Isao; Anai, Satoshi; Miyake, Makito; Morizawa, Yosuke; Hori, Shunta; Owari, Takuya; Fujii, Tomomi; Ohbayashi, Chiho; Yamaki, Kaori; Hasegawa, Masatoshi; Fujimoto, Kiyohide Journal: International journal of urology Issue: Volume 27:Number 9(2020) Page Start: 755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer. (January 2019) Authors: Onishi, Kenta; Tanaka, Nobumichi; Miyake, Makito; Nakai, Yasushi; Anai, Satoshi; Torimoto, Kazumasa; Yamaki, Kaori; Asakawa, Isao; Hasegawa, Masatoshi; Fujii, Tomomi; Konishi, Noboru; Fujimoto, Kiyohide Journal: Clinical and translational radiation oncology Issue: Volume 14(2019) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil. (10th August 2021) Authors: Maesaka, Fumisato; Tanaka, Nobumichi; Nakai, Yasushi; Asakawa, Isao; Tomizawa, Mitsuru; Owari, Takuya; Miyake, Makito; Anai, Satoshi; Yamaki, Kaori; Fujii, Tomomi; Hasegawa, Masatoshi; Fujimoto, Kiyohide Journal: International journal of urology Issue: Volume 28:Number 11(2021) Page Start: 1171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Coverage of the external prostatic region by the hybrid method compared with the conventional method of prostate low‐dose‐rate brachytherapy: A randomized controlled study. (11th August 2020) Authors: Tanaka, Nobumichi; Asakawa, Isao; Nakai, Yasushi; Miyake, Makito; Anai, Satoshi; Yamaki, Kaori; Fujii, Tomomi; Hasegawa, Masatoshi; Fujimoto, Kiyohide Journal: International journal of urology Issue: Volume 27:Number 11(2020) Page Start: 1013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Erectile dysfunction and sexual quality of life in patients who underwent low‐dose‐rate brachytherapy alone for prostate cancer. (24th October 2021) Authors: Nakai, Yasushi; Tanaka, Nobumichi; Asakawa, Isao; Miyake, Makito; Anai, Satoshi; Yamaki, Kaori; Hasegawa, Masatoshi; Fujimoto, Kiyohide Journal: Andrologia Issue: Volume 54:Number 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Factors affecting urinary frequency after low‐dose‐rate brachytherapy for prostate cancer. Issue 1 (20th July 2021) Authors: Uematsu, Toshitaka; Torimoto, Kazumasa; Tanaka, Nobumichi; Asakawa, Isao; Hori, Shunta; Yamaki, Kaori; Nakai, Yasushi; Miyake, Makito; Anai, Satoshi; Hasegawa, Masatoshi; Fujimoto, Kiyohide Journal: LUTS Issue: Volume 14:Issue 1(2022) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of neoadjuvant androgen deprivation therapy on postimplant prostate D90 and prostate volume after low‐dose‐rate brachytherapy for localized prostate cancer. (11th November 2021) Authors: Owari, Takuya; Tanaka, Nobumichi; Nakai, Yasushi; Miyake, Makito; Anai, Satoshi; Torimoto, Kazumasa; Maesaka, Fumisato; Asakawa, Isao; Yamaki, Kaori; Fuji, Tomomi; Hasegawa, Masatoshi; Fujimoto, Kiyohide Journal: International journal of urology Issue: Volume 29:Number 2(2022) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Linac-based fractionated stereotactic radiotherapy with a micro-multileaf collimator for large brain metastasis unsuitable for surgical resection. (17th June 2020) Authors: Matsuda, Ryosuke; Tamamoto, Tetsuro; Sugimoto, Tadashi; Hontsu, Shigeto; Yamaki, Kaori; Miura, Sachiko; Takeshima, Yasuhiro; Tamura, Kentaro; Yamada, Shuichi; Nishimura, Fumihiko; Nakagawa, Ichiro; Motoyama, Yasushi; Park, Young-Su; Nakase, Hiroyuki; Hasegawa, Masatoshi Journal: Journal of radiation research Issue: Volume 61:Number 4(2020:Jul.) Page Start: 546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low‐dose‐rate brachytherapy. (20th September 2022) Authors: Tanaka, Nobumichi; Nakai, Yasushi; Asakawa, Isao; Yamaki, Kaori; Miyake, Makito; Hori, Shunta; Owari, Takuya; Fujii, Tomomi; Fujimoto, Kiyohide Journal: International journal of urology Issue: Volume 29:Number 12(2022) Page Start: 1560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone. (28th October 2019) Authors: Nakai, Yasushi; Tanaka, Nobumichi; Asakawa, Isao; Anai, Satoshi; Miyake, Makito; Morizawa, Yosuke; Hori, Shunta; Owari, Takuya; Fujii, Tomomi; Yamaki, Kaori; Hasegawa, Masatoshi; Fujimoto, Kiyohide Journal: Japanese journal of clinical oncology Issue: Volume 50:Number 1(2020) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗